WELCOME TO HYPAHEALTH™
We translate promising scientific discoveries into actionable medicine to help patients
HypaHealth™ focuses on understanding the patterns and underlying mechanisms of diseases. Our mission is to make therapy work for all patients. Our AI-enabled, multiscale Responsive-Treatment™ platform coalesces high-dimensional disease and drug properties using multimodal machine learning and advanced bioinformatics to discover novel biomarkers, new targets, and treatment criteria, as well as to repurpose existing or to find new drugs for superior treatment outcomes.
RESEARCH, TECHNOLOGIES & DISCOVERIES
Our research involves constant analysis of the hypotheses we explore to combat different diseases. Since 2019, we have been driven by this mission of discovery to improve patients' diagnosis and treatment outcomes.
Candes AI™
Candes AI™ is our propeitary Artificial Intelligence framework that leverages AI algorithms such as deep learning and generative AI. With hundreds of terabytes of data from different modalities in conjunction with our advanced bioinformatics, our results have demonstrated high accuracy and performance in diagnostics and drug discovery.
Responsive-Treatment™
Our Responsive-Treatment™ platform is built upon our best-in-class, proprietary computational models from Candes AI™ constructed with advanced analytics and enormous data. It coalesces high-dimensional disease and drug properties using multimodal machine learning and advanced bioinformatics to discover new targets, treatment criteria, and drugs for superior treatment outcomes.
SCALABLE INFRASTRUCTURE
We run our research and systems in a highly scalable and secure infrastructure environment on the cloud powered up by our in-house cutting-edge technologies. Our state-of-the-art infrastructure, HypaHub™, enables us and our collaborators to process and analyze numerous research and patient data with high-dimensional features. Our environment is HIPAA compliant to protect all sensitive data.
SOLUTIONS
Faster and better treatments by our multiscale, personalized medicine approach
IMPROVED
TRIALS
Multiscale high-precision subtyping to improve clinical trial recruitment
TARGETED
THERAPY
AI-enabled identification of drugs or combination drugs for targeted therapy
ACCURATE DIAGNOSTICS
Multimodal biomarkers for accurate early detection and
diagnostics
SIGN UP
Sign up now to partner with us and experience our Responsive-Treatment™ platform powered by our proprietary Candes AI™ technology for diagnostics and drug discovery.
Already have an account? Sign in here